Huang Zhimin, Li Yanbing, Tang Tianyi, Xu Wen, Liao Zhihong, Yao Bin, Hu Guoliang, Weng Jianping
Department of Endocrinology and Diabetes Centre, The First Affiliated Hospital of Sun Yat-sen University, #58 Zhongshan Er Road, Guangzhou, Guangdong, P.R. China.
Clin Endocrinol (Oxf). 2009 Nov;71(5):659-65. doi: 10.1111/j.1365-2265.2009.03525.x. Epub 2009 Jan 19.
Mutations in the insulin receptor (IR) gene are known to cause severe insulin resistance. Although clinical features due to a mutation can be diverse, hypoglycaemia is found in some cases. A family with a female proband diagnosed with type A insulin resistance syndrome was studied. Clinical characteristics were compared with the Arginine1174Glutamine (R1174N) mutation reported in the literature.
The proband was a 16-year-old girl who was presented with intermittent hypoglycaemia, hirsutism, darkened skin, acne and oligomenorrhoea. A 5-h oral glucose tolerance test (OGTT), intravenous glucose tolerance test and continuous glucose monitoring system were performed for evaluation of glucose metabolism and insulin secretion. Results from a hyperinsulinaemic euglycaemic clamp on the proband were compared to nine normal glucose tolerance (NGT) controls. The IR gene of the proband, along with her parents and two dizygotic twin brothers were scanned for mutations by direct sequencing.
Elevated serum insulin and insulin : C-peptide ratios were found in the proband, the father and one of the twin brothers, carried a heterozygous missense mutation of Arginine1174Tryptophan (R1174W) in exon20 of the IR gene. The clamp study showed that the nonoxidative glucose disposal rates of the proband were near zero, and that the metabolic clearance rate for insulin was markedly reduced.
R1174 of the IR gene may be a candidate locus for hyperinsulinaemic hypoglycaemia. Clinical heterogeneity is not uncommon within families as well as among mutation carriers with different amino acid replacements. More pedigrees and long-term follow-up data are needed to document the evolution of beta-cell function and clarify the role of R1174 on insulin resistance and hyperinsulinaemic hypoglycaemia.
胰岛素受体(IR)基因突变可导致严重的胰岛素抵抗。虽然由突变引起的临床特征可能多种多样,但在某些病例中会出现低血糖。对一个以A型胰岛素抵抗综合征确诊的女性先证者的家系进行了研究。将临床特征与文献中报道的精氨酸1174谷氨酰胺(R1174N)突变进行了比较。
先证者为一名16岁女孩,表现为间歇性低血糖、多毛、皮肤变黑、痤疮和月经过少。进行了5小时口服葡萄糖耐量试验(OGTT)、静脉葡萄糖耐量试验和持续葡萄糖监测系统,以评估葡萄糖代谢和胰岛素分泌。将先证者的高胰岛素正常血糖钳夹试验结果与9名糖耐量正常(NGT)对照者进行比较。通过直接测序对先证者及其父母和两个异卵双胞胎兄弟的IR基因进行突变扫描。
先证者、其父亲和其中一个双胞胎兄弟血清胰岛素和胰岛素:C肽比值升高,在IR基因外显子20中携带精氨酸1174色氨酸(R1174W)的杂合错义突变。钳夹研究表明,先证者的非氧化葡萄糖处置率接近零,胰岛素的代谢清除率显著降低。
IR基因的R1174可能是高胰岛素血症性低血糖的候选位点。临床异质性在家族内部以及具有不同氨基酸替代的突变携带者之间并不罕见。需要更多的家系和长期随访数据来记录β细胞功能的演变,并阐明R1174在胰岛素抵抗和高胰岛素血症性低血糖中的作用。